Literature DB >> 35482197

Yeast Display Guided Selection of pH-Dependent Binders.

Jenna N Meanor1, Albert J Keung1, Balaji M Rao1,2, Nimish Gera3.   

Abstract

pH-dependent antigen binding has proven useful in engineering next-generation therapeutics specifically via antibody recycling technology. This technology allows for half-life extension, thereby lowering the amount and frequency of dosing of therapeutics. Cell sorting, coupled with display techniques, has been used extensively for the selection of high-affinity binders. Herein, we describe a cell sorting methodology utilizing yeast surface display for selection of binding proteins with strong binding at physiological pH and weak to no binding at acidic pH. This methodology can be readily applied to engineer proteins and/or antibodies that do not have pH-dependent binding or for selection of de novo pH-dependent binders using library-based methods.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antibody recycling; Cell sorting; Half-life extension; Histidine scanning; Yeast surface display; pH-dependent binding

Mesh:

Substances:

Year:  2022        PMID: 35482197     DOI: 10.1007/978-1-0716-2285-8_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  19 in total

Review 1.  Protein selection using yeast surface display.

Authors:  Nimish Gera; Mahmud Hussain; Balaji M Rao
Journal:  Methods       Date:  2012-03-23       Impact factor: 3.608

2.  An improved yeast transformation method for the generation of very large human antibody libraries.

Authors:  Lorenzo Benatuil; Jennifer M Perez; Jonathan Belk; Chung-Ming Hsieh
Journal:  Protein Eng Des Sel       Date:  2010-02-03       Impact factor: 1.650

Review 3.  Applications of Yeast Surface Display for Protein Engineering.

Authors:  Gerald M Cherf; Jennifer R Cochran
Journal:  Methods Mol Biol       Date:  2015

4.  Increasing serum half-life and extending cholesterol lowering in vivo by engineering antibody with pH-sensitive binding to PCSK9.

Authors:  Javier Chaparro-Riggers; Hong Liang; Rachel M DeVay; Lanfang Bai; Janette E Sutton; Wei Chen; Tao Geng; Kevin Lindquist; Meritxell Galindo Casas; Leila M Boustany; Colleen L Brown; Jeffrey Chabot; Bruce Gomes; Pamela Garzone; Andrea Rossi; Pavel Strop; Dave Shelton; Jaume Pons; Arvind Rajpal
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

5.  Design of pH sensitive binding proteins from the hyperthermophilic Sso7d scaffold.

Authors:  Nimish Gera; Andrew B Hill; Dalon P White; Ruben G Carbonell; Balaji M Rao
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

6.  A generic approach to engineer antibody pH-switches using combinatorial histidine scanning libraries and yeast display.

Authors:  Christian Schröter; Ralf Günther; Laura Rhiel; Stefan Becker; Lars Toleikis; Achim Doerner; Janine Becker; Andreas Schönemann; Daichi Nasu; Berend Neuteboom; Harald Kolmar; Björn Hock
Journal:  MAbs       Date:  2015       Impact factor: 5.857

7.  Maximizing in vivo target clearance by design of pH-dependent target binding antibodies with altered affinity to FcRn.

Authors:  Danlin Yang; Craig Giragossian; Steven Castellano; Marcio Lasaro; Haiguang Xiao; Himanshu Saraf; Cynthia Hess Kenny; Irina Rybina; Zhong-Fu Huang; Jennifer Ahlberg; Tammy Bigwarfe; Maria Myzithras; Erica Waltz; Simon Roberts; Rachel Kroe-Barrett; Sanjaya Singh
Journal:  MAbs       Date:  2017-08-08       Impact factor: 5.857

8.  Construction of pH-sensitive Her2-binding IgG1-Fc by directed evolution.

Authors:  Michael W Traxlmayr; Elisabeth Lobner; Christoph Hasenhindl; Gerhard Stadlmayr; Chris Oostenbrink; Florian Rüker; Christian Obinger
Journal:  Biotechnol J       Date:  2014-08       Impact factor: 4.677

9.  Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action.

Authors:  Douglas Sheridan; Zhao-Xue Yu; Yuchun Zhang; Rekha Patel; Fang Sun; Melissa A Lasaro; Keith Bouchard; Bruce Andrien; Andre Marozsan; Yi Wang; Paul Tamburini
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

10.  Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases.

Authors:  Taku Fukuzawa; Zenjiro Sampei; Kenta Haraya; Yoshinao Ruike; Meiri Shida-Kawazoe; Yuichiro Shimizu; Siok Wan Gan; Machiko Irie; Yoshinori Tsuboi; Hitoshi Tai; Tetsushi Sakiyama; Akihisa Sakamoto; Shinya Ishii; Atsuhiko Maeda; Yuki Iwayanagi; Norihito Shibahara; Mitsuko Shibuya; Genki Nakamura; Takeru Nambu; Akira Hayasaka; Futa Mimoto; Yuu Okura; Yuji Hori; Kiyoshi Habu; Manabu Wada; Takaaki Miura; Tatsuhiko Tachibana; Kiyofumi Honda; Hiroyuki Tsunoda; Takehisa Kitazawa; Yoshiki Kawabe; Tomoyuki Igawa; Kunihiro Hattori; Junichi Nezu
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.